Early accumulation of abnormally thick mucus and inflammation in the lungs, rather than bacterial infections, may be the…
Articles by Ana Pena, PhD
Resura Prenatal Test, the first non-invasive prenatal test for single-gene (monogenic) disorders such as cystic fibrosis…
Eloxx Pharmaceuticals presented new positive preclinical data for ELX-02, its lead treatment candidate for cystic fibrosis (CF),…
Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for…
A new method to estimate the best dose of enzyme supplements for pancreatic enzyme replacement…
Amphotericin B, a widely used antifungal medication, may be a potential treatment to restore lung mucus properties, including its…
Joint disease, or arthropathy, is common among people with cystic fibrosis (CF), and more likely to occur…
An inhaled form of messenger RNA (mRNA) with the potential to safely deliver therapeutics to the lungs of cystic…
The effects of CFTR modulator therapies such as Kalydeco (ivacaftor) can be more reliably assessed using a test that specifically measures…
Cystic fibrosis (CF) patients with liver disease do not experience greater lung function decline compared with CF…